Search results
Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System
WKBN 27 Youngstown· 4 days agoHyalex Orthopaedics, a privately held medical device company developing cartilage repair products based on the transformative HYALEX® materials platform, today announced that patients have successfully ...
Cochlear receives FDA clearance to lower the age for the Osia System to 5-years-old
Napa Valley Register· 7 days agoFood and Drug Administration (FDA) clearance to lower the age of the Cochlear™ Osia System from 12...
GREENBROOK TMS REPORTS FISCAL YEAR 2023 OPERATIONAL AND FINANCIAL RESULTS
ABC 26 New Orleans· 7 hours agoGreenbrook TMS Inc. (OTCQB: GBNHF) ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this ...
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the...
Morningstar· 4 days agoKrystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the first patient was dosed in its Phase 1 clinical trial (KYANITE-1) evaluating ...
Scilex Holding Company Announces $15 Million Registered Direct Offering
Morningstar· 2 days agoScilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products ...
When Advocacy Turns Into Obstruction: A Cautionary Tale for Corporate Counsel Handling Gov't...
Law.com· 2 days agoAll three faced unprecedented challenges when their companies came under federal investigation. Most...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 21 hours agoPhase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary...
WFRV 5 Green Bay· 15 hours agoCBL-514 is under development for multiple indications, including Cellulite, Local Fat Reduction (currently in Phase 2b), and Durum's disease (currently in Phase 2), which brought Caliway the ...
Cochlear receives FDA clearance to lower the age for the Osia System to 5-years-old
Casper Star-Tribune· 7 days agoFood and Drug Administration (FDA) clearance to lower the age of the Cochlear™ Osia System from 12...
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
WKBN 27 Youngstown· 21 hours agoRA'ANANA, Israel, April 25, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, ...